249 Results

People

  1. Berger
    Berger
  2. Offit
    Offit
  3. Solit
    Solit
  4. Ladanyi
    Ladanyi
  5. Reis-Filho
    Reis-Filho
  6. Riely
    Riely
  7. Robson
    Robson
  8. Abdel-Wahab
    Abdel-Wahab
  9. Aghajanian
    Aghajanian
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (136)
  2. GSK Faculty (105)
  3. Solid Tumor Oncology Division (89)
  4. Department of Pathology and Laboratory Medicine (71)
  5. Hematologic Malignancies, Division of (54)
  6. Sloan Kettering Institute Postdocs (54)
  7. Center for Hematologic Malignancies (51)
  8. Human Oncology and Pathogenesis Program (51)
  9. Tow Center for Developmental Oncology (TCDO) (48)
  10. Epidemiology and Biostatistics (42)
  1. "mutations"
Formats
  1. Journal Article (226)
  2. Review (10)
  3. Guidelines (4)
  4. Editorial (3)
  5. Meeting Abstract (3)
  6. Conference Paper (2)
  7. Research Letter (1)
Groups
  1. Department of Medicine (136)
  2. GSK Faculty (105)
  3. Solid Tumor Oncology Division (89)
  4. Department of Pathology and Laboratory Medicine (71)
  5. Hematologic Malignancies, Division of (54)
  6. Sloan Kettering Institute Postdocs (54)

More Groups

People
  1. Michael Berger (17)
  2. Kenneth Offit (15)
  3. David Solit (14)
  4. Marc Ladanyi (12)
  5. Zsofia Stadler (11)
  6. Gregory Riely (10)

More People

Years
  1. 2025 (5)
  2. 2024 (7)
  3. 2023 (19)
  4. 2022 (31)
  5. 2021 (28)
  6. 2020 (17)

More Years

Publications
  1. Clinical Cancer Research (14)
  2. JCO Precision Oncology (10)
  3. Blood (8)
  4. American Journal of Surgical Pathology (7)
  5. Cancer Discovery (7)
  6. Journal of Clinical Oncology (7)

More Publications

Publishers
  1. Nature Publishing Group (36)
  2. American Association for Cancer Research (33)
  3. Elsevier Inc. (18)
  4. American Society of Clinical Oncology (17)
  5. American Society of Hematology (15)
  6. Lippincott Williams & Wilkins (15)

More Publishers

Results (249)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Blood vessel epicardial substance reduces LRP6 receptor and cytoplasmic beta-catenin levels to modulate Wnt signaling and intestinal homeostasis
    Journal Article

    Thompson, J. J.; Short, S. P.; Parang, B.; Brown, R. E.; Li, C.; Ng, V. H.; Saito-Diaz, K.; Choksi, Y. A.; Washington, M. K.; Smith, J. J.; more...
    Carcinogenesis (2019)

    Fulltext@MSK | Save
  • Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: Results from the IMMUNOTARGET registry
    Journal Article

    Mazieres, J.; Drilon, A.; Lusque, A.; Mhanna, L.; Cortto, A. B.; Mezquita, L.; Thai, A. A.; Mascaux, C.; Couraud, S.; Veillon, R.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • An integrative approach reveals genetic complexity and epigenetic perturbation in acute promyelocytic leukemia: A single institution experience
    Journal Article

    Rahimi, N.; Zhang, Y.; Mina, A.; Altman, J. K.; Sukhanova, M.; Frankfurt, O.; Jennings, L.; Lu, X.; Behdad, A.; Chen, Q.; more...
    Human Pathology (2019)

    Fulltext@MSK | Save
  • Altered nuclear export signal recognition as a driver of oncogenesis
    Journal Article

    Taylor, J.; Sendino, M.; Gorelick, A. N.; Pastore, A.; Chang, M. T.; Penson, A. V.; Gavrila, E. I.; Stewart, C.; Melnik, E. M.; Herrejon Chavez, F.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • Acquired MET exon 14 alteration drives secondary resistance to epidermal growth factor receptor tyrosine kinase inhibitor in EGFR-mutated lung cancer
    Journal Article

    Suzawa, K.; Offin, M.; Schoenfeld, A. J.; Plodkowski, A. J.; Odintsov, I.; Lu, D.; Lockwood, W. W.; Arcila, M. E.; Rudin, C. M.; Drilon, A.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Ultra-deep next-generation sequencing of plasma cell-free DNA in patients with advanced lung cancers: Results from the Actionable Genome Consortium
    Journal Article

    Li, B. T.; Janku, F.; Jung, B.; Hou, C.; Madwani, K.; Alden, R.; Razavi, P.; Reis-Filho, J. S.; Shen, R.; Isbell, J. M.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Abnormal oxidative metabolism in a quiet genomic background underlies clear cell papillary renal cell carcinoma
    Journal Article

    Xu, J.; Reznik, E.; Lee, H. J.; Gundem, G.; Jonsson, P.; Sarungbam, J.; Bialik, A.; Sanchez-Vega, F.; Creighton, C. J.; Hoekstra, J.; more...
    eLife (2019)

    Fulltext@MSK | Save
  • Ampullary cancer: Evaluation of somatic and germline genetic alterations and association with clinical outcomes
    Journal Article

    Wong, W.; Lowery, M. A.; Berger, M. F.; Kemel, Y.; Taylor, B.; Zehir, A.; Srinivasan, P.; Bandlamudi, C.; Chou, J.; Capanu, M.; more...
    Cancer (2019)

    Fulltext@MSK | Save
  • Characterizing recurrent and lethal small renal masses in clear cell renal cell carcinoma using recurrent somatic mutations
    Journal Article

    Manley, B. J.; Reznik, E.; Ghanaat, M.; Kashan, M.; Becerra, M. F.; Casuscelli, J.; Tennenbaum, D.; Redzematovic, A.; Carlo, M. I.; Sato, Y.; more...
    Urologic Oncology: Seminars and Original Investigations (2019)

    Fulltext@MSK | Save
  • Real-time genomic characterization of metastatic pancreatic neuroendocrine tumors has prognostic implications and identifies potential germline actionability
    Journal Article

    Raj, N.; Shah, R.; Stadler, Z.; Mukherjee, S.; Chou, J.; Untch, B.; Li, J.; Kelly, V.; Osoba, M.; Saltz, L. B.; more...
    JCO Precision Oncology (2018)

    Fulltext@MSK | Save